WallStreetZenWallStreetZen

NASDAQ: ADVM
Adverum Biotechnologies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Adverum Biotechnologies revenue was $1.00M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADVM annual revenue was $1.0M, with -72.2% growth year-over-year.

ADVM past revenue growth

How has ADVM's revenue growth performed historically?

Company
-72.22%
Industry
497.69%
Market
20.68%
ADVM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADVM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ADVM's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ADVM revenue history

Current Revenue
$1.0M
Current Earnings
-$130.9M
Current Profit Margin
-13,092.7%

Be the first to know when ADVM announces revenue.

ADVM Revenue History By Year

ADVM Yearly RevenueADVM RevenueADVM ChangeADVM Revenue Growth
2024-12-31$1.00M-$2.60M-72.22%
2023-12-31$3.60MN/AN/A
2022-12-31$0.00-$7.50M-100.00%
2021-12-31$7.50MN/AN/A
2020-12-31$0.00-$250.00k-100.00%
2019-12-31$250.00k-$1.36M-84.49%
2018-12-31$1.61M-$237.00k-12.82%
2017-12-31$1.85M$394.00k+27.08%
2016-12-31$1.46M-$864.00k-37.26%
2015-12-31$2.32M$1.75M+305.42%
2014-12-31$572.00k$92.00k+19.17%
2013-12-31$480.00k$450.00k+1,500.00%
2012-12-31$30.00kN/AN/A

1 of 1

Adverum Biotechnologies Revenue FAQ

What was ADVM's revenue last quarter?

On Invalid Date, Adverum Biotechnologies (NASDAQ: ADVM) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Adverum Biotechnologies's revenue was $0.00.

What was Adverum Biotechnologies's revenue in 2024?

Adverum Biotechnologies's annual revenue for the twelve months ending Dec 31, 2024 was $1.00 million, a 72.22% decrease year over year.

How much does Adverum Biotechnologies make in a day?

Based on Adverum Biotechnologies annual revenue for the past five years, ADVM makes an average of $6,630.14 per day.

What was Adverum Biotechnologies's annual revenue growth in the past year?

As of Q2 2025, Adverum Biotechnologies's revenue has grown -72.22% year over year. This is 569.92 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Adverum Biotechnologies's revenue in the past year totaled $1.00 million.

How much does Adverum Biotechnologies make in a year?

Adverum Biotechnologies's revenue by year for the past five years is:
  • Adverum Biotechnologies's revenue for the twelve months ending Dec 31, 2024 was $1.00 million, a 72.22% decrease year over year.
  • Adverum Biotechnologies's annual revenue for Dec 31, 2023 was $3.60 million, a Infinity% increase from 2022.
  • Adverum Biotechnologies's annual revenue for 2022 was $0.00, a 100% decrease from 2021.
  • Adverum Biotechnologies's annual revenue for 2021 was $7.50 million, a Infinity% increase from 2020.
  • Adverum Biotechnologies's annual revenue for 2020 was $0.00, a 100% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.